When people ask me why I got interested in peptides beyond GLP-1s, this one usually comes up first. BPC-157 stands for Body Protection Compound — a 15-amino-acid peptide originally derived from a protein found in human gastric juice. Researchers first isolated it in the 1990s and have been studying it ever since, mostly in animals.[1]
What Is It, Exactly?
Your stomach lining produces a protective protein called gastric juice protein. Scientists extracted a small, highly stable fragment from it and called it BPC-157. That stability is a big deal — most peptides break down quickly in the body, but BPC-157 appears to remain active in the gut environment, which is exactly where it was found to begin with.[2]
Researchers got interested because patients with certain inflammatory bowel conditions seemed to have lower levels of this protective gastric protein. That observation sparked decades of animal trials looking at whether supplementing with the isolated fragment could help repair tissue.
What the Research Shows
The honest answer is: a lot, in animals — less in confirmed human studies. That gap matters, and I'll come back to it. But the preclinical data is substantial enough that it's worth understanding.
Gut and GI Healing
This is where BPC-157 research started and where the evidence is strongest. Multiple animal studies have shown it to help heal gastric ulcers, repair intestinal fistulas, and reduce inflammation in models of inflammatory bowel disease.[3] The proposed mechanism involves upregulation of growth factors — particularly VEGF (vascular endothelial growth factor) — which promotes the growth of new blood vessels (angiogenesis) in damaged tissue.[4]
Tendon and Ligament Repair
This is where BPC-157 has picked up a serious following among athletes and people recovering from injury. Several rat studies have shown accelerated healing of severed tendons and ligaments, with researchers noting that treated animals regained strength and range of motion faster than controls.[5] The mechanism appears to involve fibroblast (connective tissue cell) activation and increased collagen synthesis at injury sites.[6]
Systemic Effects
Animal research has also pointed toward neuroprotective effects, including potential recovery from peripheral nerve injury, and some anti-inflammatory effects in the brain.[7] This has prompted interest from people dealing with chronic pain conditions. Again — these are animal models, not human trials.
"BPC-157 works on multiple pathways simultaneously — that's what makes it fascinating scientifically and hard to pin down clinically. It's not hitting one receptor; it's influencing signaling cascades that touch healing across organ systems."
How It's Used
BPC-157 is typically administered via subcutaneous injection or intramuscular injection, often near the site of injury. Some protocols use oral or intranasal routes, though researchers note that oral delivery may be better suited for GI conditions while injected delivery reaches systemic circulation more reliably.[8]
Dosing in animal studies has ranged widely. Physicians and compounding pharmacies working with this compound typically use protocols in the 250–500 mcg per day range, though I want to be clear: there's no established human dosing protocol from approved clinical trials.
My Personal Take
I find this one scientifically compelling — the mechanism makes intuitive sense, and the volume of animal research is genuinely impressive. What keeps me measured is the gap between animal studies and human trials. We've seen peptides with strong preclinical profiles not replicate in human studies before.
For me, BPC-157 represents what I love about Peptide U by BritePear: following the science honestly, understanding the mechanism, and making informed decisions with a physician — not chasing a trend.
If you have a history of gut issues, chronic tendon injuries, or systemic inflammation and you're working with a forward-thinking physician, this is absolutely worth an educated conversation.